What substances or conditions can cause a false positive result for oxycodone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

False Positive Oxycodone Results

The most clinically significant cause of false-positive oxycodone results is oral naltrexone, which metabolizes to noroxymorphone and can trigger positive oxycodone immunoassays. 1

Primary Causes of False-Positive Oxycodone Results

Naltrexone (Most Important)

  • Oral naltrexone metabolizes to noroxymorphone, a lesser-known metabolite that directly causes false-positive oxycodone results on standard immunoassay screening 1
  • This false-positive can occur repeatedly in patients stabilized on oral naltrexone for alcohol or opioid use disorder 1
  • Confirmatory testing with gas chromatography-mass spectrometry (GC-MS) will detect noroxymorphone rather than oxycodone, definitively proving the false-positive 1

Cross-Reactivity from Other Opioids

  • Oxymorphone, the metabolite of oxycodone, can be detected by oxycodone immunoassays and may represent metabolism from actual oxycodone use rather than independent oxymorphone use 2
  • High-dose morphine (with urine levels in the 15,000-28,000 mg/mL range) has been documented to cause false-positive results on some opioid immunoassays, though this was specifically reported for buprenorphine screens 3

Drug Impurities

  • Hydrocodone can be present as an impurity in oxycodone pills at concentrations up to 1%, and hydrocodone or its metabolite hydromorphone may be detected in patients taking only oxycodone 4
  • When the ratio of hydrocodone to oxycodone or hydromorphone to oxycodone is <1%, this likely represents an impurity rather than independent drug use 4

Critical Testing Limitations

Immunoassay Screening Tests

  • Standard opiate immunoassays poorly detect oxycodone because it is a semisynthetic opioid, which is why specific oxycodone immunoassays were developed 5
  • Immunoassay screening tests are presumptive only and susceptible to cross-reactions, requiring confirmation by GC-MS when results are unexpected or will impact clinical decisions 2, 6, 7
  • The sensitivity threshold of immunoassays may be too high to detect therapeutic levels of oxycodone, potentially causing false-negative results 8

Detection Variability

  • Many laboratories now use specific oxycodone immunoassays that detect both oxycodone and oxymorphone, improving detection compared to traditional opiate screens 2
  • The combination of traditional opiate immunoassays with specific oxycodone immunoassays provides 98% sensitivity and specificity for opioid detection 5

Essential Clinical Approach

Before Making Any Clinical Decisions

  • Obtain a complete medication history, specifically asking about naltrexone (oral or injectable), all prescribed opioids, over-the-counter medications, and supplements 7, 9
  • Discuss unexpected results with the patient in a non-judgmental manner before ordering confirmatory testing, as this can sometimes yield a candid explanation 2
  • Contact your laboratory or toxicologist to understand which specific substances are included in their testing panel and the detection thresholds used 2, 7

Confirmatory Testing Requirements

  • Request GC-MS confirmatory testing before making any consequential clinical decisions, such as dismissing patients from care, making punitive decisions, or assuming medication diversion 2, 6, 7, 10
  • GC-MS can definitively identify specific opioids and metabolites, distinguishing true oxycodone use from false-positives caused by naltrexone metabolites or other cross-reacting substances 2, 1
  • If GC-MS detects noroxymorphone rather than oxycodone in a patient taking oral naltrexone, this confirms the false-positive 1

Critical Pitfalls to Avoid

  • Never dismiss patients from care or make punitive decisions based solely on immunoassay results without confirmatory testing, as this constitutes patient abandonment and could have severe adverse consequences 2, 10
  • Do not assume that a positive oxycodone result always indicates illicit use or diversion—metabolites from prescribed medications (like oxymorphone from oxycodone) can cause positive results 2
  • Be aware that false-positive results can have severe consequences in some states, including loss of child custody or legal implications 6, 7
  • Understand that drug testing cannot distinguish between appropriate use and misuse of prescribed medications 7

References

Guideline

prevention and control of seasonal influenza with vaccines.

MMWR Recommendations and Reports, 2016

Guideline

Interpreting Urine Drug Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bupropion and Urine Drug Screens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clonazepam Detection Limitations and Clinical Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What does a positive drug screen for opiates, cocaine, and oxycodone indicate in a patient receiving oxycodone, tramadol, and acetaminophen (Tylenol) in the hospital and taking Norco (hydrocodone/acetaminophen) at home?
If a patient receives morphine, will the opiate panel be positive on a urine toxicology screen?
Can buprenorphine (Subutex) tests yield false positive results?
Can a patient be treated with tramadol concurrently with naltrexone?
Can a Department of Transportation (DOT) driver pass a DOT physical examination if they admit to failing a non-DOT drug screen?
What is the recommended initial treatment regimen for an 11-year-old patient with Attention Deficit Hyperactivity Disorder (ADHD) starting stimulant medication, considering potential pre-existing medical conditions?
What are the next steps for a patient with a skin condition who is not responding to triamcinolone (corticosteroid) ointment?
What are the executive functions as described by Russell Barkley?
What are the effects of statins, such as atorvastatin (Lipitor) or simvastatin (Zocor), on mitochondria in patients with a history of mitochondrial disease?
What adjustments can be made to the medication regimen of a patient taking Vraylar (cariprazine) 1.5 mg, Lexapro (escitalopram) 20 mg, Hydroxyzine 50 mg, Lamotrigine 200 mg, and Duloxetine 60 mg, who is experiencing anxiety, irregular sleep, and mood changes?
When should tapping or paracentesis be performed or avoided in a patient with liver failure, gross ascites, and hypoalbuminemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.